Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

A

AKTX

Akari Therapeutics Plc ADR

8.18

Oct 16 • 3:59 PM ET -0.66 (-7.47%)

8.51

Aftermarket • 4:15 PM ET +0.33 (4.03%)

Healthcare Biotechnology USA Nano NASD

Peers: IKT NBP NERV NVCT ALXO BCYC CGEN FATE FHTX CDXS

Scroll to Statements

Index	-
Market Cap	14.32M
Enterprise Value	7.26M
Income	-30.90M
Sales	0.00M
Book/sh	10.62
Cash/sh	4.43
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	6
IPO	May 07, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.77
P/C	1.85
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.60
Current Ratio	0.60
Debt/Eq	0.04
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-17.25
EPS next Y	-5.49
EPS next Q	-2.23
EPS this Y	52.32%
EPS next Y	44.32%
EPS next 5Y	46.65%
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	1.39%
Sales Q/Q	-
Earnings	Aug 13 AMC
EPS/Sales Surpr.	100.00% -

Insider Own	0.40%
Insider Trans	0.00%
Inst Own	8.71%
Inst Trans	243.35%
ROA	-69.02%
ROE	-139.80%
ROIC	-166.16%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-8.55%
SMA50	-9.79%
SMA200	-11.07%
Trades

Shs Outstand	1.75M
Shs Float	1.74M
Short Float	0.83%
Short Ratio	0.24
Short Interest	0.01M
52W High	33.60 -75.65%
52W Low	3.02 171.31%
Volatility	13.39% 11.59%
ATR (14)	1.03
RSI (14)	44.27
Beta	1.46
Rel Volume	0.35
Avg Volume	61.36K
Volume	21,689

Perf Week	-6.73%
Perf Month	-17.16%
Perf Quarter	-23.26%
Perf Half Y	41.03%
Perf YTD	-29.24%
Perf Year	-73.44%
Perf 3Y	-94.07%
Perf 5Y	-99.38%
Perf 10Y	-99.88%
Recom	1.00
Target Price	25.50
Prev Close	8.84
Price	8.18
Change %	-7.47%

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)